Breast Cancer | Current Treatment | EU5 | 2021
Insights on EU5 medical oncologists’ prescribing practices and key factors influencing their treatment decisions for HR-positive/HER2-negative breast cancer patients.
Find logins to all Clarivate products below.
Insights on EU5 medical oncologists’ prescribing practices and key factors influencing their treatment decisions for HR-positive/HER2-negative breast cancer patients.